Abstract: An apparatus for measuring a jugular vein pressure waveform includes a rotation sensor configured to produce a measurement signal when being against a skin of an individual and in a movement sensing relation with a jugular vein of the individual. The apparatus includes a processing system configured to receive the measurement signal and produce a waveform of a motion of the skin in a direction perpendicular to the skin based on the measurement signal indicative of rotation of the rotation sensor, where the waveform of the motion of the skin is indicative of the jugular vein pressure waveform. The rotation sensor that measures rotation is more insensitive to movements not related to variation of the jugular vein pressure than for example an acceleration sensor.

Abstract: A wearable neurostimulation device is provided for providing transcutaneous peripheral nerve stimulation to a user. The neurostimulation device may include an enclosure housing the electronics for generating electric neurostimulation signals and an adjustable band detachably coupled to the enclosure. The enclosure may include a stimulation button and one or more auxiliary buttons. The band may be configured to be worn by a user, such as around the user's wrist or arm. The band may include a locking tab which prevents the loop from being opened. The band may comprise electrodes positioned to stimulate the user's radial and median nerves. Also provided is a charger for holding and charging the neurostimulation device. The band may include an RFID tag that wireless communicates with an RFID antenna in the charger. The charger may not charge the neurostimulation device if the band is determined to be beyond a threshold age.

Abstract: A method is provided that includes identifying a subject as suffering from a headache or a migraine within a head of the subject, and, in response thereto, applying electrical energy to skin on an arm, a leg, a hand, or a foot of the subject's body by driving electrical pulses into the portion of the subject's body. The electrical pulses are configured such that more than 50 percent of the applied electrical energy stimulates A-beta sensory nerve fibers, and less than 20 percent of the applied electrical energy stimulates any one of A-delta sensory nerve fibers, C sensory nerve fibers, and motor nerve fibers. Other embodiments are also described.

Abstract: A system may include at least one medical device and a processing system. The medical device may be configured to treat a condition by delivering a therapy to a patient. The therapy is at least partially defined using a parameter set. The processing system may be configured for use to acquire clinical effect data (CED) for the condition, acquire a medication state of medication administered to treat the condition, adjust the CED based on the medication state to provide medication-adjusted CED, and identify an adjusted parameter set for the at least one medical device to deliver the therapy based on the medication-adjusted CED. The adjusted parameter set may be communicated to a clinician (or patient or other user) as a suggestion or may be automatically implemented to update the therapy.

Abstract: A medical device system determines first values associated with a first plurality of patient parameters associated with arrhythmic substrate and/or physiological triggers for acute cardiac events based on a first one or more of the physiological signals generated during the period and determines, based on the first values associated with the first plurality of patient parameters, whether to assess alterations in cardiac cellular electrophysiology and/or mechanical alterations of the patient. The system may, in response to determining to assess the alterations in cardiac cellular electrophysiology, determine second values associated with a second plurality of patient parameters relating to cardiac electrophysiology based on a second one or more of the physiological signals generated during the period and determine whether to generate an alert indicating that an acute cardiac event of the patient is predicted based at least in part on the second values associated with the second plurality of patient parameters.

Abstract: An implantable medical device (IMD) and process are provided comprising one or more electrodes configured to be implanted to define a pacing vector through at least a portion of a ventricle. Sensing circuitry is configured to sense intrinsic atrial activity (As) and intrinsic ventricular activity (Vs). A pulse generator (PG) if provided, and memory configured to store program instructions and an atrioventricular delay search parameter (AVDSEARCH). The AVDSEARCH is an interval of time. One or more processors, that when executing the program instructions, is configured to direct the PG to deliver ventricular pacing pulses based on an atrioventricular delay (AVD) and periodically initiate an AVD search operation utilizing the AVDSEARCH. A heart rate is determined and compared to a threshold. Responsive to determining that the heart rate exceeds the threshold, the AVDSEARCH is reduced, and cardiac activity is detected during the AVD search operation utilizing the reduced AVDSEARCH.

Abstract: Embodiments of the present disclosure provide a small form factor ECG monitoring device that can acquire 3 standard ECG leads including a V-lead, does not require the use of adhesives for electrodes, and provides ECG data for a user on a near instantaneous basis. The ECG monitoring device can acquire leads I, II, and V2 (or any other V lead). The addition of a V-lead not only provides an additional channel of ECG data, but also adds another orthogonal cardiac field plane (the horizontal plane) thanks to the reference point formed by leads I and II. The ECG monitoring device may derive the augmented limb leads and subsequently generate a full 12-lead ECG. The ECG monitoring device may generate one or more diagnoses based on the full 12-lead set. The ECG monitoring device may provide an easy and non-invasive way for a person to take an ECG on the fly.

Abstract: A light emitting device includes a light source configured to emit a primary light, a first phosphor that absorbs the primary light and converts the primary light into a first wavelength-converted light having a wavelength longer than that of the primary light, and a second phosphor that absorbs the primary light and converts the primary light into a second wavelength-converted light having a wavelength longer than that of the primary light. The first wavelength-converted light is a fluorescence having a light component over an entire wavelength range of 700 nm or more to 800 nm or less. The second wavelength-converted light is a fluorescence having a peak where a fluorescence intensity shows a maximum value in a wavelength range of 380 nm or more to less than 700 nm. The first wavelength-converted light has a 1/10 afterglow time longer than that of the second wavelength-converted light.

Abstract: A magnetic resonance guided laser ablation treatment system, including: an optical fiber cooling assembly (400), accommodating and cooling an ablation optical fiber (5); a laser ablation apparatus (200), including a laser generator and a cooling device; a stereotactic driving system (300), accommodating and controlling the position and angle of rotation of the ablation optical fiber (5); and a workstation (100), configured to control the movement of a stereotactic driving system, and generate and display ablation information of the target region during the workflow of the magnetic resonance guided laser ablation treatment system by using the magnetic resonance temperature imaging technology.

Abstract: Various aspects of this disclosure relate to a layered polymer substrate with electrodes and conductive ink embedded in the substrate. In some embodiments, a prosthetic liner may be bonded onto the polymer substrate. The substrate may include an interconnect coupled to the electrodes via the conductive ink. The system may include a controller (e.g., an electrode controller) in communication with the electrodes via the conductive ink. The electrodes may be activated such that they may stimulate nerve fibers in a user's residual limb.

Abstract: A clinical evaluation system and method are disclosed that facilitate the use of one or more visual features or parameters determined from biophysical signals such as cardiac/biopotential signals and/or photoplethysmography signals that are acquired, in preferred embodiments, non-invasively from surface sensors placed on a patient while the patient is at rest. The visual features or parameters can be used in a model or classifier (e.g., a machine-learned classifier) to estimate metrics associated with the physiological state of a patient, including for the presence or non-presence of a disease, medical condition, or an indication of either. The estimated metric may be used to assist a physician or other healthcare provider in diagnosing the presence or non-presence and/or severity and/or localization of diseases or conditions or in the treatment of said diseases or conditions.

Abstract: A method of acutely activating the noradrenergic systems in a subject can comprise applying one or more electrical pulses to an ear canal (e.g., the left ear canal) of the subject, wherein the one or more electrical pulses are sufficient to acutely activate the noradrenergic system of the subject. Apparatuses and systems for applying one or more electrical pulses to an ear canal are also disclosed.

Abstract: A wearable medical device is provided. The device includes electrodes to receive electrical signals from a patient, monitor for a cardiac arrhythmia, and provide a therapeutic shock to the patient in response to detecting the arrhythmia. The device includes a user interface to receive patient input indicating initiation or termination of a high-noise activity. The device can include accelerometers to generate motion signals. The device includes a processor to monitor for initiation or termination of the high-noise activity based on a noise level in the electrical signals, the motion signals, and the patient input. The processor can cause, in response to the initiation of the high-noise activity, an arrhythmia detection process to execute in an activity-induced noise (AIN) robust mode, and cause, in response to the termination of the high-noise activity, the arrhythmia detection process to execute in an AIN sensitive mode.

Abstract: The invention relates to a wearable device for determining a nature of motion and/or a physiological state of a wearer. The wearable device comprises a body portion configured to be worn by the wearer and at least one sensor mounted to the body portion configured to, while the wearable device is being worn, detect a motion parameter of the wearer and/or a physiological parameter of the wearer and generate input data indicative of the motion parameter and/or the physiological parameter. The wearable device further comprises a processor configured to receive the input data from the at least one sensor and process the input data by executing an algorithm to determine the nature of motion and/or the physiological state of the wearer while the wearable device is being worn. The invention further relates to a system for determining a nature of motion and/or a physiological state of a wearer.

Abstract: Apparatus (20) for ophthalmic treatment includes an optical unit (30), which includes a camera (54), which is configured to capture an image of an eye (25) of a patient, a laser (48), which is configured to emit pulses of laser radiation, and beam conditioning and scanning optics (49, 50), which are configured to focus and direct the laser radiation to impinge on an anterior surface of the eye. A controller (44) is configured to analyze the image so as to identify a limbus of the eye, and to control the optical unit so that the laser radiation impinges on a set of one or more locations on the anterior surface of the eye that are in a vicinity of the limbus with a pulse duration and an energy selected so as to stem cells at the one or more locations.

Abstract: Red light therapy devices are disclosed which is substantially more powerful and treats a provided in-contact treatment of a substantially larger area of the human body compared with red light therapy devices previously known in the art. The design is ergonomically versatile, allowing relaxed comfortable treatment of hand, wrist, arm, leg knee, ankle, foot, neck, face, and back. A safety cap for a hand-held red light therapy unit is disclosed. A safety improvement for a hand-held red light therapy unit is disclosed which eases alignment and reduces chance of short-circuit. A bed adapter for stand-up red light therapy panels is disclosed. Flexible light guides for red light therapy treatment are disclosed. An adaptor for adapting a red light therapy head to a clinical treatment stand is disclosed. An open-bottom 3-D-printer-mounted hotbox for increasing the quality of fused deposition modeling 3-D printed parts for red light therapy devices is disclosed.

Abstract: An implantable medical device system is configured to detect a tachyarrhythmia from a cardiac electrical signal and start an ATP therapy delay period. The implantable medical device determines whether the cardiac electrical signal received during the ATP therapy delay period satisfies ATP delivery criteria. A therapy delivery module is controlled to cancel the delayed ATP therapy if the ATP delivery criteria are not met and deliver the delayed ATP therapy if the ATP delivery criteria are met.

Abstract: A method of collecting physiological parameter data of a monitored subject comprises measuring a biosignal from which the physiological parameter is deducible, including noise; converting the noisy measured biosignal to a vector having different frequency components with corresponding magnitude coefficients; discarding select frequency components with coefficients below a prescribed threshold; and communicating the reduced vector to a computing device for processing to deduce the physiological parameter. A method of processing physiological parameter data comprises receiving a measured biosignal with electromagnetic interference noise; obtaining from the noisy measured biosignal representative data using a machine learning algorithm; and determining the physiological parameter from the representative data.

Abstract: Described herein are methods, devices and systems for efficiently storing data for sensed biological signals. A sensed biological signal, or an amplitude and/or filtered version thereof, is provided to an N-bit ADC of an IMD to produce an N-bit data value indicative of an amplitude of the biological signal at a point in time. One of a plurality of chords of a compression curve is selected, based on a magnitude of the N-bit data value, and used to produce an M-bit data value, which is a compressed version of the N-bit data value, wherein M<N. The M-bit data value is stored as an M-bit data slice within memory of the IMD, and can be expanded to a reproduced N-bit data value after being uploaded to a non-implanted device or system.

Abstract: A portable device for quantitative measurement of tissue autoregulation and neurovascular coupling via portable measurement of blood flow, oxygenation, metabolism, and/or EEG signals and methods for using said device. The device may comprise a body and a plurality of legs pivotably attached to the body. The plurality of legs may comprise at least one reference electrode leg and at least one measurement electrode leg for electrical measurement, and an optical detection fiber leg and at least one optical source fiber leg for optical blood flow, oxygenation, and metabolism measurement. The present invention is additionally directed to a portable device for blood flow measurement and therapeutic photobiomodulation. The device may comprise a body and a plurality of legs. The plurality of legs may comprise at least one optical detection fiber leg and at least one optical source fiber leg, and at least one leg for therapeutic photobiomodulation.